https://www.lw.com/en/news/2024/09/latham-watkins-advises-ascendis-pharma-in-us150-million-royalty-financing
Multidisciplinary team represents the biopharmaceutical company in the royalty agreement with Royalty Pharma.
latham watkinsroyalty financingadvisesascendispharma